AstraZeneca
AZN
AZN
1,014 hedge funds and large institutions have $34.8B invested in AstraZeneca in 2022 Q2 according to their latest regulatory filings, with 113 funds opening new positions, 310 increasing their positions, 355 reducing their positions, and 68 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.79% more ownership
Funds ownership: 33.34% → 34.12% (+0.79%)
13% less repeat investments, than reductions
Existing positions increased: 310 | Existing positions reduced: 355
15% less call options, than puts
Call options by funds: $386M | Put options by funds: $457M
Holders
1,014
Holding in Top 10
24
Calls
$386M
Puts
$457M
Top Buyers
| 1 | +$546M | |
| 2 | +$347M | |
| 3 | +$293M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$157M |
| 5 |
DCP
DSM Capital Partners
Palm Beach Gardens,
Florida
|
+$115M |
Top Sellers
| 1 | -$545M | |
| 2 | -$194M | |
| 3 | -$101M | |
| 4 |
SIG
Senator Investment Group
New York
|
-$99.5M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$88.2M |